Stock Earnings Crinetics Pharmaceuticals Inc [NASDAQ: CRNX] Sees Decrease in Stock Value Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Crinetics Pharmaceuticals
Analysts Viewpoint Crinetics Pharmaceuticals Inc (CRNX) receives a Neutral rating from Goldman Crinetics Pharmaceuticals Inc’s filing revealed that its Chief Scientific Officer Betz Stephen F. unloaded Company’s shares for reported $3.14 million
Stock Earnings Crinetics Pharmaceuticals Inc [CRNX] stock for 3,141,877 USD was sold by Betz Stephen F. Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its